We also tested whether the presence or severity of symptoms of IBS and the levels of proinflammatory cytokines, brain-derived neurotrophic factor, and other blood markers would predict or influence response to treatment [53]. The gene discussed is BDNF; the disease is irritable bowel syndrome.